Invention Publication
- Patent Title: HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB
-
Application No.: US18525282Application Date: 2023-11-30
-
Publication No.: US20240245792A1Publication Date: 2024-07-25
- Inventor: Giovanni Abbadessa , Carolina E. Caffaro , Brigitte Demers , Joseph Leveque , Wan-Ju Meng , Marcos Milla , Jerod Ptacin
- Applicant: Synthorx, Inc. , MSD INTERNATIONAL GMBH , MSD INTERNATIONAL BUSINESS GMBH
- Applicant Address: US CA La Jolla
- Assignee: Synthorx, Inc.,MSD INTERNATIONAL GMBH,MSD INTERNATIONAL BUSINESS GMBH
- Current Assignee: Synthorx, Inc.,MSD INTERNATIONAL GMBH,MSD INTERNATIONAL BUSINESS GMBH
- Current Assignee Address: US CA La Jolla
- Main IPC: A61K47/64
- IPC: A61K47/64 ; A61K39/00 ; A61P35/04 ; C07K16/22 ; C07K16/28
Abstract:
Disclosed herein are methods for treating head and neck squamous cell carcinoma (HNSCC) in a subject in need thereof, comprising administering IL-2 conjugates in combination with one or more additional agents.
Information query
IPC分类:
